Exploring the Anti-Diabetic Potential of Quercetagitrin through Dual Inhibition of PTPN6 and PTPN9
Open Access
Abstract
Protein tyrosine phosphatases (PTPs) are pivotal contributors to the development of type 2 diabetes (T2DM). Hence, directing interventions towards PTPs emerges as a valuable therapeutic approach for managing type 2 diabetes. In particular, PTPN6 and PTPN9 are targets for anti-diabetic effects. Through high-throughput drug screening, quercetagitrin (QG) was recognized as a dual-target inhibitor of PTPN6 and PTPN9. We observed that QG suppressed the catalytic activity of PTPN6 (IC50 = 1 μM) and PTPN9 (IC50 = 1.7 μM) in vitro and enhanced glucose uptake by mature C2C12 myoblasts. Additionally, QG increased the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and insulin-dependent phosphorylation of Akt in mature C2C12 myoblasts. It further promoted the phosphorylation of Akt in the presence of palmitic acid, suggesting the attenuation of insulin resistance. In summary, our results indicate QG’s role as a potent inhibitor targeting both PTPN6 and PTPN9, showcasing its potential as a promising treatment avenue for T2DM.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2012M3A9C4048775, 2022M3A9G8084563, 2022M3A9G8017838)
This publication has 53 references indexed in Scilit:
- Cooperative BindingPLOS Computational Biology, 2013
- A Highly Selective and Potent PTP-MEG2 Inhibitor with Therapeutic Potential for Type 2 DiabetesJournal of the American Chemical Society, 2012
- PTP1B and TCPTP – nonredundant phosphatases in insulin signaling and glucose homeostasisThe FEBS Journal, 2012
- Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformationJournal of Cellular Biochemistry, 2011
- Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currentsJournal of Molecular and Cellular Cardiology, 2010
- Large-Scale Structural Analysis of the Classical Human Protein Tyrosine PhosphatomeCell, 2009
- Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Reverses the Adverse Effects of Diet-Induced Obesity on Oocyte QualityEndocrinology, 2008
- Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic ratsPhytomedicine, 2006
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling PathwaysJournal of Biological Chemistry, 2002